...
首页> 外文期刊>Diagnostic cytopathology >Evaluation of a scoring system for predicting lymph node malignancy in ultrasound guided fine needle aspiration practice
【24h】

Evaluation of a scoring system for predicting lymph node malignancy in ultrasound guided fine needle aspiration practice

机译:超声引导下细针抽吸术中评估淋巴结恶性评分系统的评估

获取原文
获取原文并翻译 | 示例
           

摘要

Ultrasound-guided fine needle aspiration (USG-FNA) has enabled cytopathologists to accurately diagnose smaller or non-palpable lymph nodes (LN) on a regular basis. Pre-FNA clinical and ultrasonographic factors, such as a patient's age, ratio of short to long axis diameter (S/L ratio), internal echogenicity, and the vascular pattern of a LN, are reported to be able to predict the benign or malignant nature of a LN. This study is designed to test the formula "0.06 × (age) + 4.76 × (S/L ratio) + 2.15 × (internal echo) + 1.80 × (vascular pattern)" generated from the study of Liao et al. as a scoring system for predicting LN malignancy in a cytopathologist operated USG-FNA practice. Eighty-three reports of USG-FNA of LNs issued between 7/1/2008 and 4/28/2010 were reviewed. Patient's age, S/L ratio, internal echo, and vascular pattern were used to generate scores based on the aforementioned formula. A score of seven was used as a cutoff for predicting benign (<7) and malignant (>7) LNs. FNA cytology diagnosis, flow cytometric analysis as well as subsequent surgical diagnosis in some cases served as gold standard for statistical analysis. Among 46 USG-FNA of LNs with scores > 7, 38 were malignant and eight were benign. All 37 USG-FNA of LNs with scores < 7 were proven to be benign. The scoring system achieved 100% sensitivity, 82% specificity, 83% positive predictive value, 100% negative predictive value, and 90% accuracy. Further study of the eight "false-positive" cases revealed that three of them (37.5%) were found to be malignant in follow-up FNA and/or surgical biopsy. This scoring system may serve as a complementary tool in determining how aggressive a FNA procedure should be performed, how a FNA sample of LN should be triaged for ancillary study, and how closely a patient with lymphadenopathy should be followed up.
机译:超声引导的细针穿刺术(USG-FNA)使细胞病理学家能够定期准确地诊断较小或不可触及的淋巴结(LN)。据报道,FNA前的临床和超声检查因素能够预测良性或恶性,例如患者的年龄,短轴与长轴直径的比(S / L比),内部回声和LN的血管形态LN的性质。本研究旨在测试由廖等人的研究得出的公式“ 0.06×(年龄)+ 4.76×(S / L比)+ 2.15×(内部回波)+ 1.80×(血管模式)”。作为在细胞病理学家操作的USG-FNA实践中预测LN恶性评分系统。审查了2008年7月1日至2010年4月28日发布的LN的USG-FNA的八十三份报告。根据上述公式,使用患者的年龄,S / L比,内部回声和血管模式生成评分。 7分被用作预测良性(<7)和恶性(> 7)LN的临界值。在某些情况下,FNA细胞学诊断,流式细胞术分析以及随后的手术诊断是进行统计分析的金标准。在得分> 7的46个USG-FNA LN中,恶性38个,良性8个。分数<7的所有37个USG-FNA LN都被证明是良性的。评分系统实现了100%的敏感性,82%的特异性,83%的阳性预测值,100%的阴性预测值和90%的准确性。对8例“假阳性”病例的进一步研究表明,其中3例(37.5%)在随访FNA和/或手术活检中被发现是恶性的。该评分系统可以作为确定FNA程序执行的积极性,LN的FNA样本应如何进行分类以进行辅助研究以及对淋巴结病患者进行密切随访的辅助工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号